Healthcare
Monday, May 23, 2016
BRIEF-Novartis: Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency
* Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment